300 related articles for article (PubMed ID: 19402863)
1. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
[TBL] [Abstract][Full Text] [Related]
2. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
4. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
[TBL] [Abstract][Full Text] [Related]
6. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD
Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058
[TBL] [Abstract][Full Text] [Related]
7. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Mogarekar MR; Talekar SJ
Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
9. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
Paragh G; Seres I; Harangi M; Pocsai Z; Asztalos L; Locsey L; Szeles G; Kardos L; Varga E; Karpati I; Adany R
Nephron Clin Pract; 2009; 113(1):c46-53. PubMed ID: 19602899
[TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V
Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
13. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis.
Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW
Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase phenotype distribution in a healthy Iranian population.
Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M
Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
18. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs.
Kasprzak M; Iskra M; Majewski W; Wielkoszyński T
Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644
[TBL] [Abstract][Full Text] [Related]
19. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease].
Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O
Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543
[TBL] [Abstract][Full Text] [Related]
20. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
